Avantor, Inc. (NYSE:AVTR) is Robeco Schweiz AG’s 2nd Largest Position

Robeco Schweiz AG boosted its stake in Avantor, Inc. (NYSE:AVTR) by 12.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,612,555 shares of the company’s stock after acquiring an additional 848,814 shares during the quarter. Avantor comprises about 3.4% of Robeco Schweiz AG’s holdings, making the stock its 2nd largest holding. Robeco Schweiz AG owned approximately 1.12% of Avantor worth $160,397,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. State Street Corp raised its position in shares of Avantor by 58.0% in the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after purchasing an additional 8,206,695 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Avantor by 18.2% in the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock valued at $457,710,000 after purchasing an additional 2,719,615 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Avantor by 7.1% in the 3rd quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company’s stock valued at $287,791,000 after purchasing an additional 739,667 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Avantor by 653.0% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock valued at $159,740,000 after acquiring an additional 5,354,678 shares in the last quarter. Finally, CCLA Investment Management raised its position in shares of Avantor by 4.5% during the 4th quarter. CCLA Investment Management now owns 5,357,703 shares of the company’s stock valued at $112,940,000 after acquiring an additional 229,199 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the topic of several research reports. Morgan Stanley dropped their price target on Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. UBS Group reissued a “neutral” rating and set a $25.00 price target (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Barclays dropped their price target on Avantor from $26.00 to $23.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Royal Bank of Canada dropped their price target on Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a research report on Monday, February 10th. Finally, Raymond James reissued an “outperform” rating and set a $24.00 price target (down from $26.00) on shares of Avantor in a research report on Monday, February 10th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Avantor presently has an average rating of “Moderate Buy” and a consensus target price of $25.92.

Avantor Price Performance

Shares of AVTR opened at $17.22 on Thursday. Avantor, Inc. has a 12 month low of $17.14 and a 12 month high of $28.00. The company has a market cap of $11.73 billion, a P/E ratio of 16.56, a PEG ratio of 1.55 and a beta of 1.28. The stock has a fifty day moving average price of $20.69 and a 200 day moving average price of $22.79. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the previous year, the business earned $0.22 earnings per share. On average, research analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.